Role of Urine Toxicology Testing in the Management of Chronic Opioid Therapy
暂无分享,去创建一个
[1] C. Selavka. Poppy seed ingestion as a contributing factor to opiate-positive urinalysis results: the Pacific perspective. , 1991, Journal of forensic sciences.
[2] M. Erjavec,et al. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. , 1997, The Clinical journal of pain.
[3] K. Carroll. Methodological issues and problems in the assessment of substance use , 1995 .
[4] R. de la Torre,et al. Recommendations for the Reliable Detection of Illicit Drugs in Urine in the European Union, with Special Attention to the Workplace , 1997, Annals of clinical biochemistry.
[5] H. W. Clark,et al. Opioid use in the treatment of chronic pain: assessment of addiction. , 1993, Journal of pain and symptom management.
[6] M. Holden,et al. A method for the confirmation and identification of drugs of misuse in urine using solid phase extraction and gas-liquid chromatography with mass spectrometry. , 1998, Journal of clinical pathology.
[7] R. Braithwaite,et al. Screening for Drugs of Abuse. I: Opiates, Amphetamines and Cocaine , 1995, Annals of clinical biochemistry.
[8] R. Wennig. Threshold values in toxicology - useful or not? , 2000, Forensic science international.
[9] A. Christophersen,et al. Drug analysis for control purposes in forensic toxicology, workplace testing, sports medicine and related areas. , 1994, Pharmacology & toxicology.
[10] R. Portenoy,et al. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. , 1996, Journal of pain and symptom management.
[11] Nathaniel Katz,et al. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases. , 1996, Journal of pain and symptom management.
[12] D J Crouch,et al. Laboratory validation study of drug evaluation and classification program: alprazolam, d-amphetamine, codeine, and marijuana. , 1998, Journal of analytical toxicology.
[13] J. Turner,et al. Self-reported vs. actual use of medications in chronic pain patients , 1982, Pain.
[14] K. Kalasinsky,et al. Assessment of the ion-trap mass spectrometer for routine qualitative and quantitative analysis of drugs of abuse extracted from urine. , 2000, Journal of analytical toxicology.
[15] M. Weissman,et al. Best estimate of lifetime psychiatric diagnosis: a methodological study. , 1982, Archives of general psychiatry.
[16] R. Zeeuw. Recent developments in analytical toxicology: for better or for worse , 1998 .
[17] D. Canfield,et al. Role of metabolites in aviation forensic toxicology. , 1995, Aviation Space and Environmental Medicine.
[18] E. Cone,et al. Disposition of heroin and its metabolites in heroin-related deaths. , 1994, Journal of analytical toxicology.
[19] S. Fishman,et al. The opioid contract in the management of chronic pain. , 1999, Journal of pain and symptom management.
[20] D. Fishbain,et al. Drug Abuse, Dependence, and Addiction in Chronic Pain Patients , 1992, The Clinical journal of pain.
[21] J. Galloway,et al. Detection of drug misuse--an addictive challenge. , 1999, Journal of clinical pathology.
[22] P. Bendtsen,et al. What are the qualities of dilemmas experienced when prescribing opioids in general practice? , 1999, Pain.
[23] R. Jamison. Comprehensive pretreatment and outcome assessment for chronic opioid therapy in nonmalignant pain. , 1996, Journal of pain and symptom management.
[24] E. Sellers,et al. Inhibition of cytochrome P450 2D6 metabolism of hydrocodone to hydromorphone does not importantly affect abuse liability. , 1997, The Journal of pharmacology and experimental therapeutics.
[25] J. Valentine,et al. Use of a visual panel detection method for drugs of abuse: clinical and laboratory experience with children and adolescents. , 1995, The Journal of pediatrics.
[26] R. Parker,et al. High prevalence of recent cocaine use and the unreliability of patient self-report in an inner-city walk-in clinic. , 1992, JAMA.
[27] K. Miotto,et al. Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. , 1998, Journal of pain and symptom management.
[28] L. Davis,et al. Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. , 2000, Drug and alcohol dependence.
[29] D. Fishbain,et al. Validity of self-reported drug use in chronic pain patients. , 1999, The Clinical journal of pain.
[30] D. Crouch,et al. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results. , 1998, Journal of forensic sciences.